Logo image of CBZ

CBIZ INC (CBZ) Stock Fundamental Analysis

NYSE:CBZ - New York Stock Exchange, Inc. - US1248051021 - Common Stock - Currency: USD

75.96  +1.47 (+1.97%)

After market: 75.96 0 (0%)

Fundamental Rating

4

CBZ gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 82 industry peers in the Professional Services industry. CBZ has a medium profitability rating, but doesn't score so well on its financial health evaluation. CBZ is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CBZ had positive earnings in the past year.
In the past year CBZ had a positive cash flow from operations.
In the past 5 years CBZ has always been profitable.
CBZ had a positive operating cash flow in each of the past 5 years.
CBZ Yearly Net Income VS EBIT VS OCF VS FCFCBZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.92%, CBZ is in line with its industry, outperforming 40.24% of the companies in the same industry.
Looking at the Return On Equity, with a value of 2.31%, CBZ is in line with its industry, outperforming 40.24% of the companies in the same industry.
The Return On Invested Capital of CBZ (2.21%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CBZ is significantly below the industry average of 13.58%.
The last Return On Invested Capital (2.21%) for CBZ is well below the 3 year average (6.53%), which needs to be investigated, but indicates that CBZ had better years and this may not be a problem.
Industry RankSector Rank
ROA 0.92%
ROE 2.31%
ROIC 2.21%
ROA(3y)4.15%
ROA(5y)4.39%
ROE(3y)10.79%
ROE(5y)10.71%
ROIC(3y)6.53%
ROIC(5y)6.32%
CBZ Yearly ROA, ROE, ROICCBZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CBZ's Profit Margin of 2.26% is in line compared to the rest of the industry. CBZ outperforms 46.34% of its industry peers.
In the last couple of years the Profit Margin of CBZ has declined.
With a Operating Margin value of 6.38%, CBZ perfoms like the industry average, outperforming 58.54% of the companies in the same industry.
CBZ's Operating Margin has declined in the last couple of years.
CBZ has a worse Gross Margin (10.34%) than 85.37% of its industry peers.
CBZ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.38%
PM (TTM) 2.26%
GM 10.34%
OM growth 3Y-10.26%
OM growth 5Y-4.48%
PM growth 3Y-29.35%
PM growth 5Y-21.21%
GM growth 3Y-10.5%
GM growth 5Y-4.73%
CBZ Yearly Profit, Operating, Gross MarginsCBZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CBZ is destroying value.
The number of shares outstanding for CBZ has been increased compared to 1 year ago.
CBZ has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CBZ is higher compared to a year ago.
CBZ Yearly Shares OutstandingCBZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CBZ Yearly Total Debt VS Total AssetsCBZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 1.70, we must say that CBZ is in the distress zone and has some risk of bankruptcy.
CBZ has a worse Altman-Z score (1.70) than 62.20% of its industry peers.
The Debt to FCF ratio of CBZ is 12.79, which is on the high side as it means it would take CBZ, 12.79 years of fcf income to pay off all of its debts.
CBZ has a Debt to FCF ratio (12.79) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.76 indicates that CBZ is somewhat dependend on debt financing.
The Debt to Equity ratio of CBZ (0.76) is worse than 62.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 12.79
Altman-Z 1.7
ROIC/WACC0.28
WACC7.99%
CBZ Yearly LT Debt VS Equity VS FCFCBZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.18 indicates that CBZ should not have too much problems paying its short term obligations.
CBZ has a Current ratio of 1.18. This is comparable to the rest of the industry: CBZ outperforms 46.34% of its industry peers.
A Quick Ratio of 1.18 indicates that CBZ should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.18, CBZ perfoms like the industry average, outperforming 47.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.18
CBZ Yearly Current Assets VS Current LiabilitesCBZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

8

3. Growth

3.1 Past

CBZ shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.56%.
The Earnings Per Share has been growing by 15.05% on average over the past years. This is quite good.
The Revenue has grown by 13.97% in the past year. This is quite good.
Measured over the past years, CBZ shows a quite strong growth in Revenue. The Revenue has been growing by 13.84% on average per year.
EPS 1Y (TTM)7.56%
EPS 3Y16%
EPS 5Y15.05%
EPS Q2Q%23.08%
Revenue 1Y (TTM)13.97%
Revenue growth 3Y17.96%
Revenue growth 5Y13.84%
Sales Q2Q%40.52%

3.2 Future

CBZ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.65% yearly.
CBZ is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.93% yearly.
EPS Next Y42.69%
EPS Next 2Y27.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year66.01%
Revenue Next 2Y31.93%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CBZ Yearly Revenue VS EstimatesCBZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
CBZ Yearly EPS VS EstimatesCBZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 29.67 indicates a quite expensive valuation of CBZ.
Compared to the rest of the industry, the Price/Earnings ratio of CBZ indicates a slightly more expensive valuation: CBZ is more expensive than 62.20% of the companies listed in the same industry.
CBZ is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.33, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 20.79, CBZ is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBZ is on the same level as its industry peers.
CBZ is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.37, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 29.67
Fwd PE 20.79
CBZ Price Earnings VS Forward Price EarningsCBZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

70.73% of the companies in the same industry are cheaper than CBZ, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBZ is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 37.07
EV/EBITDA 33.16
CBZ Per share dataCBZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CBZ's earnings are expected to grow with 27.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.7
PEG (5Y)1.97
EPS Next 2Y27.65%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CBZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CBIZ INC

NYSE:CBZ (4/22/2025, 7:00:00 PM)

After market: 75.96 0 (0%)

75.96

+1.47 (+1.97%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-26 2025-02-26/bmo
Earnings (Next)04-24 2025-04-24/bmo
Inst Owners91.53%
Inst Owner Change0.09%
Ins Owners4.04%
Ins Owner Change-1.9%
Market Cap4.11B
Analysts85.71
Price Target100.47 (32.27%)
Short Float %2.86%
Short Ratio4.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.7%
Min EPS beat(2)9.91%
Max EPS beat(2)17.49%
EPS beat(4)3
Avg EPS beat(4)-3.83%
Min EPS beat(4)-43.49%
Max EPS beat(4)17.49%
EPS beat(8)6
Avg EPS beat(8)-0.59%
EPS beat(12)9
Avg EPS beat(12)2.58%
EPS beat(16)12
Avg EPS beat(16)2.29%
Revenue beat(2)1
Avg Revenue beat(2)5.23%
Min Revenue beat(2)-1.62%
Max Revenue beat(2)12.08%
Revenue beat(4)1
Avg Revenue beat(4)2.11%
Min Revenue beat(4)-1.71%
Max Revenue beat(4)12.08%
Revenue beat(8)5
Avg Revenue beat(8)2.59%
Revenue beat(12)9
Avg Revenue beat(12)3.97%
Revenue beat(16)13
Avg Revenue beat(16)4.43%
PT rev (1m)0%
PT rev (3m)1.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)28.07%
EPS NY rev (1m)17.62%
EPS NY rev (3m)17.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)68.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)32.23%
Valuation
Industry RankSector Rank
PE 29.67
Fwd PE 20.79
P/S 2.26
P/FCF 37.07
P/OCF 33.2
P/B 2.31
P/tB N/A
EV/EBITDA 33.16
EPS(TTM)2.56
EY3.37%
EPS(NY)3.65
Fwd EY4.81%
FCF(TTM)2.05
FCFY2.7%
OCF(TTM)2.29
OCFY3.01%
SpS33.55
BVpS32.93
TBVpS-21.56
PEG (NY)0.7
PEG (5Y)1.97
Profitability
Industry RankSector Rank
ROA 0.92%
ROE 2.31%
ROCE 3.07%
ROIC 2.21%
ROICexc 2.22%
ROICexgc 10.32%
OM 6.38%
PM (TTM) 2.26%
GM 10.34%
FCFM 6.11%
ROA(3y)4.15%
ROA(5y)4.39%
ROE(3y)10.79%
ROE(5y)10.71%
ROIC(3y)6.53%
ROIC(5y)6.32%
ROICexc(3y)6.56%
ROICexc(5y)6.34%
ROICexgc(3y)21.85%
ROICexgc(5y)20.77%
ROCE(3y)9.09%
ROCE(5y)8.79%
ROICexcg growth 3Y-18.93%
ROICexcg growth 5Y-6.45%
ROICexc growth 3Y-27.55%
ROICexc growth 5Y-15.96%
OM growth 3Y-10.26%
OM growth 5Y-4.48%
PM growth 3Y-29.35%
PM growth 5Y-21.21%
GM growth 3Y-10.5%
GM growth 5Y-4.73%
F-Score3
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 12.79
Debt/EBITDA 8.25
Cap/Depr 26.87%
Cap/Sales 0.71%
Interest Coverage 4.51
Cash Conversion 75.53%
Profit Quality 269.94%
Current Ratio 1.18
Quick Ratio 1.18
Altman-Z 1.7
F-Score3
WACC7.99%
ROIC/WACC0.28
Cap/Depr(3y)38.86%
Cap/Depr(5y)40%
Cap/Sales(3y)0.92%
Cap/Sales(5y)0.96%
Profit Quality(3y)163.09%
Profit Quality(5y)166.86%
High Growth Momentum
Growth
EPS 1Y (TTM)7.56%
EPS 3Y16%
EPS 5Y15.05%
EPS Q2Q%23.08%
EPS Next Y42.69%
EPS Next 2Y27.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.97%
Revenue growth 3Y17.96%
Revenue growth 5Y13.84%
Sales Q2Q%40.52%
Revenue Next Year66.01%
Revenue Next 2Y31.93%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.42%
EBIT growth 3Y5.86%
EBIT growth 5Y8.74%
EBIT Next Year154.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-15.08%
FCF growth 3Y-3.22%
FCF growth 5Y5.61%
OCF growth 1Y-19.42%
OCF growth 3Y-1.95%
OCF growth 5Y4.72%